6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: January 4, 2018
Period of Report: January 4, 2018
Accession Number: 0001157523-18-000022

View Document ↗ View on SEC.gov ↗